Inhibitors against prostate-specific antigen
US6284734A · kind A · utility
0Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 24, 1998 |
| Grant date | Sep 4, 2001 |
| Priority date | — |
| Expiry date | Sep 24, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
According to the present invention, there are provided inhibitors against prostate-specific antigen which comprise as a minimum unit a peptide consisting of Gly-Phe-Tyr-Lys-Lys-Lys-Gln-Ser-Arg, and such inhibitors can be expected to constitute a therapeutic drug against prostate carcinoma and prostate hyperplasia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.